Evidence map›Paper›PMID 29588376›Full record

ArticleThe Journal of cell biology2018

TRRAP is a central regulator of human multiciliated cell formation.

Zhao Wang, Lindsey W Plasschaert, Shivani Aryal, Nicole A Renaud, Zinger Yang, Rayman Choo-Wing, Angelica D Pessotti, Nathaniel D Kirkpatrick, Nadire R Cochran, Walter Carbone and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Formation and function of multiciliated cells.The Journal of cell biology · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
  10. Human lung development: recent progress and new challenges.Development (Cambridge, England) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Zhao WangChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Lindsey W PlasschaertChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Shivani AryalChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Nicole A RenaudChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Zinger YangChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.ORCID 0000-0001-8543-4841
Rayman Choo-WingChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Angelica D PessottiChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Nathaniel D KirkpatrickAnalytical Sciences and Imaging, Novartis Institutes for BioMedical Research, Cambridge, MA.
Nadire R CochranChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Walter CarboneNovartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
Rob MaherChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Alicia LindemanChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Carsten RussChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
John Reece-HoyesChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Gregory McAllisterChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Gregory R HoffmanChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA.
Guglielmo RomaNovartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.ORCID 0000-0002-8020-4219
Aron B JaffeChemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, MA aron.jaffe@novartis.com.ORCID 0000-0002-6220-0476
Novartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multiciliated cell (MCC) is an evolutionarily conserved cell type, which in vertebrates functions to promote directional fluid flow across epithelial tissues. In the conducting airway, MCCs are generated by basal stem/progenitor cells and act in concert with secretory cells to perform mucociliary clearance to expel pathogens from the lung. Studies in multiple systems, including

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsCell LineCell LineageCiliaEpigenesis, GeneticEpithelial CellsForkhead Transcription FactorsGene Expression RegulationHumansLungNuclear ProteinsReceptor, Notch2RNA, Small InterferingSignal TransductionTranscription FactorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsForkhead Transcription FactorsFOXJ1 protein, humanMCIDAS protein, humanNuclear ProteinsReceptor, Notch2RNA, Small InterferingTranscription Factorstransformation-transcription domain-associated protein

Identifiers

PMID29588376
PMCPMC5987713
OpenAlexW2794648966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.